Peter Silberstein Selected To Join Lance Armstrong in Tour of Hope

Peter Silberstein, M.D., assistant professor of medicine and chief oncologist at Creighton University Medical Center, is among a team of 24 cancer survivors, advocates, caregivers, physicians and researchers to be selected to ride from San Diego to Washington, D.C. this fall as members of the Bristol-Myers Squibb Tour of Hope (tm). This is the third year for the cross-country journey to promote the promise of clinical trials.

As someone who works with cancer patients every day, Silberstein is passionate about enrolling them in clinical trials. In 1984, he was just finishing up his oncology fellowship when his father was first diagnosed with colon cancer. Since his father’s death, four new colon cancer drugs have been approved to treat his type of cancer. "If my father had been given the opportunity to be treated with today’s new drugs, he might possibly still be alive now," said Silberstein.

Driven by their ties to cancer, this team of avid cyclists will cover 3,300 miles of American landscape in nine days to share their experiences and inspire those they meet along the way to learn more about cancer research. Six-time Tour de France winner Lance Armstrong will lead the Team at the kick-off in San Diego and into Washington, D.C. for the finale, and will join the Team at points along the route.

Selected by members of the cancer and cycling communities from a pool of nearly 1,100 applicants, the 2005 Tour of Hope Team is comprised of people from all walks of life. The diverse group includes healthcare professionals, an Army reservist, a biologist, educators, a realtor and a sports attorney, in addition to individuals from the restaurant, software, business and investment industries.

To read more, visit : http://www.tourofhope.org/team/2005_riders/silberstein.htm